Tests brain stimulation to ease suicidal thoughts in depression
Tests brain stimulation with a mild current in adults with treatment-resistant depression.
Plain-language title generated from the registry record
Registry title: Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
Key facts
- Where
- Faye-l'Abbesse and Poitiers, FranceSee the 2 sites
Where in France
- Centre Hospitalier Nord-Deux-SèvresFaye-l'Abbesse, FranceTaking people
- Centre Hospitalier Henri LaboritPoitiers, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Hospitalier Henri Laborit
- Trial code
- NCT06009523
- Record updated
- 23 October 2026
- Original description
The main objective of this study is to demonstrate that 15 transcranial direct current stimulation (tDCS) sessions of 30 minutes at 2 mA intensity are effective to reduce suicidal ideationRead full original descriptionShow less
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation in Treatment-resistant Depression : a Pilot Study
The main objective of this study is to demonstrate that 15 transcranial direct current stimulation (tDCS) sessions of 30 minutes at 2 mA intensity are effective to reduce suicidal ideation
Inclusion: Age over 18 years; Written informed consent; Diagnosis of recurrent or isolated depressive episode according to DSM IV criteria (A.P.A. 1994); Stable antidepressant treatment for 3 weeks; MADRS score ≥ 20; SSI score > 3; Subject affiliated to a health insurance system; Woman with effective contraception and agreeing to maintain it throughout the study period.
Exclusion: Patient who has already undergone an electroconvulsive therapy course for the current episode and does not respond to this treatment; Contraindication to tDCS: intracerebral metallic implant (with the exception of dental implants), cardiac pacemaker, active or non-implanted devices in the region of the head, acute eczema in the planned stimulation area; Depression with psychotic features Axis I (DSM IV) co-morbid diagnosis of schizophrenia, alcohol and/or other substance dependence (or abuse) (lifetime); Patient deprived of liberty; Patient with high suicide risk (item 10 MADRS > 4) in the absence of hospitalization; Pregnant, parturient or breastfeeding woman; Simultaneous participation in another interventional research.